U.S. Physical Therapy (NYSE:USPH) COO Sells $85,250.00 in Stock

Key Points

• The COO of U.S. Physical Therapy, Eric Joseph Williams, sold 1,000 shares for a total of $85,250, decreasing his ownership by 3.80%.
• U.S. Physical Therapy recently announced a quarterly dividend of $0.45 per share, with a yield of 2.1% and a payout ratio of 78.60%.
• Analysts project U.S. Physical Therapy to post 2.67 EPS for the current year, with an average price target of $110.25 and a "Moderate Buy" rating on the stock.

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) COO Eric Joseph Williams sold 1,000 shares of the business's stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $85.25, for a total transaction of $85,250.00. Following the sale, the chief operating officer directly owned 25,331 shares of the company's stock, valued at approximately $2,159,467.75. The trade was a 3.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

U.S. Physical Therapy Stock Down 1.0%

USPH stock traded down $0.83 during trading on Monday, reaching $84.81. The stock had a trading volume of 140,306 shares, compared to its average volume of 142,989. U.S. Physical Therapy, Inc. has a one year low of $62.77 and a one year high of $101.19. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.30. The company's 50 day moving average is $79.79 and its two-hundred day moving average is $76.56. The company has a market capitalization of $1.29 billion, a price-to-earnings ratio of 37.03, a P/E/G ratio of 4.29 and a beta of 1.47.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.71 by $0.10. The business had revenue of $197.34 million during the quarter, compared to the consensus estimate of $190.24 million. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The firm's quarterly revenue was up 18.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.73 EPS. Equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 22nd will be paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Friday, August 22nd. U.S. Physical Therapy's payout ratio is presently 78.60%.

Wall Street Analysts Forecast Growth

USPH has been the topic of a number of recent research reports. Zacks Research upgraded shares of U.S. Physical Therapy to a "hold" rating in a research note on Friday, August 8th. Barrington Research increased their target price on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the company an "outperform" rating in a report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $110.25.

Institutional Investors Weigh In On U.S. Physical Therapy

Several institutional investors and hedge funds have recently modified their holdings of the stock. Copeland Capital Management LLC lifted its position in U.S. Physical Therapy by 8.9% during the 2nd quarter. Copeland Capital Management LLC now owns 888,735 shares of the company's stock valued at $69,499,000 after acquiring an additional 72,463 shares during the period. Geode Capital Management LLC increased its stake in U.S. Physical Therapy by 1.2% during the 2nd quarter. Geode Capital Management LLC now owns 352,923 shares of the company's stock valued at $27,602,000 after purchasing an additional 4,306 shares in the last quarter. Envestnet Asset Management Inc. increased its stake in U.S. Physical Therapy by 9.4% during the 2nd quarter. Envestnet Asset Management Inc. now owns 346,160 shares of the company's stock valued at $27,070,000 after purchasing an additional 29,671 shares in the last quarter. Bahl & Gaynor Inc. increased its stake in U.S. Physical Therapy by 32.6% during the 1st quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company's stock valued at $24,964,000 after purchasing an additional 84,878 shares in the last quarter. Finally, GW&K Investment Management LLC increased its stake in U.S. Physical Therapy by 8.9% during the 1st quarter. GW&K Investment Management LLC now owns 344,390 shares of the company's stock valued at $24,920,000 after purchasing an additional 28,203 shares in the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.